Combination therapy
OwnerEbrahim Versiinventor
Life of this patent
Estimating the term…
Abstract
The invention relates to a method of treating unstable or overactive urinary bladder, wherein the method comprises administering to a patient in need of such treatment an antimuscarinic agent in a pharmaceutically effective amount thereof and estrogen agonist in a pharmaceutically effective amount thereof. The antimuscarinic agent is preferably tolterodine or a tolterodine-related compound. The invention also relates to a pharmaceutical formulation containing an antimuscarinic agent, estrogen agonist and pharmaceutically excipients and the use of the combination for the manufacture of a therapeutical formulation for treating unstable or overactive urinary bladder.
Claims18
A method of treating unstable or overactive urinary bladder, wherein the method comprises administering to a patient in need of such treatment an antimuscarinic agent in a pharmaceutically effective amount thereof and estrogen agonist in a pharmaceutically effective amount thereof.
A pharmaceutical formulation containing an antimuscarinic agent in a pharmaceutically effective amount thereof and estrogen agonist in a pharmaceutically effective amount thereof and pharmaceutically excipients.
Use of an antimuscarinic agent in a pharmaceutically effective amount thereof and estrogen agonist in a pharmaceutically effective amount thereof for the manufacture of a therapeutical formulation for treating unstable or overactive urinary bladder.
Dependencies are inferred from the claim text.